Abstract
Introduction
Papillary squamous cell carcinoma (PSCC), a rare variant of squamous cell carcinoma (SCC) of the aerodigestive tract, has been recognized as a clinicopathologically distinct diagnosis since 1999. 1 It is associated with a more favorable prognosis than conventional SCC of the head and neck, making its correct diagnosis essential for its proper management.
In this report, the authors share a case of PSCC that presented as a routine papilloma and was treated with KTP laser photoablation and conservative follow-up.
Case report
A 34-year-old man was referred to our clinic for evaluation of a lesion on his vocal fold. He presented with hoarseness of greater than 6 months' duration, increased vocal eff ort, decreased vocal endurance, and increased vocal fatigue, demonstrated by a V-RQOL (voice-related quality of life) score of 36. He had no signifi cant history of alcohol or tobacco use, and no history of papillomatosis.
Physical examination with transnasal fl exible videostroboscopy (the patient did not tolerate rigid videostroboscopy) revealed a large, exophytic lesion of the mid-musculomembranous right true vocal fold, measuring 7 × 5 × 4 mm (fi gure 1). Th e underlying superfi cial lamina propria (SLP) that could be appreciated appeared to be unchanged. Th e lesion had a speckled blood supply, suggestive of a benign papilloma. Th ere was inadequate glottic approximation during phonation because of the presence of the lobular mass, with proper oscillation inhibited as a result. Th e lesion also exhibited increased stiff ness compared to the surrounding SLP, resulting in a diff erential pliability within each true vocal fold and between the two vocal folds.
Intraoperatively, the lesion was soft , pink-gray in color, and noted to be papillomatous in appearance (fi gure 2). Biopsies were performed (frozen biopsies were not sent because of the benign appearance of the lesion and low suspicion of malignancy), and the KTP laser was used to photoablate the vascularity of the lesion base and surrounding blood vessels.
Th e histopathologic fi ndings of the surgical specimen revealed an exophytic PSCC, with fi nger-like stromal cores and several layers of squamous epithelium (fi gure 3). Because of the nature of the treatment, invasion could not be assessed. In situ hybridization for human papillomavirus (HPV) was negative.
Although opinion diff ers regarding the need for further workup, we obtained computed tomography (CT) scans of the neck and chest with contrast, which were negative. Th e patient was returned to the operating room for a second look with marginal biopsies aft er 6 weeks, and he was followed with monthly physical and videostroboscopic examinations. Th ese were all negative for residual carcinoma.
Th e patient remained disease-free for 3 years aft er treatment and continues to be followed.
Discussion
SCC represents more than 90% of all malignant neoplasms found in the larynx. 2 Risk factors for the development of this lesion include alcohol use, tobacco use, and radiation exposure. SCCs have multiple histologic history of a previous papilloma at the primary malignant tumor site. Overall, 44% of patients died of their disease aft er multiple recurrences, with sinonasal PSCC being the most deadly site of origin; no other factors were found to have a signifi cant impact on outcome. 4 Th e relationship of PSCC with HPV has been proven to have a concordance rate as high as 40% with head and neck PSCC, 5 and a 43% concordance rate in the larynx, specifi cally. 4 Th e most common types of HPV involved in head and neck neoplasms include types 6, 11, 16, and 18. [5] [6] [7] [8] [9] It is important to note that while HPV types 6 and 11 cause benign lesions on the uterine cervix, they also have been associated with squamous malignancies when found in head and neck tumors.
Suarez et al were unable to prove HPV association with PSCC as statistically signifi cant versus benign controls, and they concluded there was no cause-specifi c survival in patients with HPV-positive tumors versus those with HPV-negative tumors; however, p53 status variants, and PSCC has recently gained favor as a distinct entity deserving a specifi c diagnosis because of its good prognosis when compared to that of conventional SCCs. 1 As was seen with our patient, it is becoming more common for patients to present at a younger age with no traditional history of risk factors for the development of SCC.
A review of 104 SCC cases conducted by Th ompson et al from 1971 to 1991 served to defi ne exophytic and papillary growth patterns and a histologic set of criteria to be used to identify these lesions. 1 Th ese authors described the exophytic growth pattern as broad-based with bulbous ends, and the papillary growth pattern as long, slender, fi nger-like projections. Although both types of growth exhibited koilocytic changes suggestive of HPV infection, only 1 case out of 41 available for slide staining in the Th ompson series was found to be HPV-positive by in situ hybridization. 1 Th ompson et al also found the distinction between exophytic and papillary patterns to have prognostic signifi cance. Exophytic and papillary type tumors recurred at similar rates, 35 and 33% respectively; however, the 5-year survival for the exophytic type was 88 versus 100% for the papillary type, as no patients with the latter type of tumors died from their disease. 1 Tumors that contained both exophytic-and papillary-type architecture behaved as exophytic tumors, and therefore they should be regarded as such for prognostic purposes.
Even though the exophytic type of SCC has a poorer prognosis than the papillary type, it is important to note that this entity has a far better prognosis than conventional SCC of the head and neck, which has an average 5-year survival rate of 50% for all stages. 3 Th ompson and colleagues concluded that medical decision making and intervention may be modifi ed based on tumor characteristics, given the overall better prognosis of these particular tumor types over conventional SCCs. 1 A clinicopathologic study of PSCCs of the upper aerodigestive tract conducted by Suarez et al determined that patients with PSCC of the larynx have the most favorable clinical outcome of all patients with PSCC of the head and neck region, based on recurrence rate and rate of metastases. 4 Th ey retrospectively studied the clinical characteristics and pathologic features of 38 cases of PSCC, with specifi c focus on the HPV infection rate and p53 protein expression. Th ey described PSCC as an exophytic proliferation of malignant squamous cells architecturally resembling a papilloma, with absent superfi cial keratinization. PSCC arose at sites where the incidence of papillomas was the highest, and 34% of Suarez et al's patient population was shown to have a PAPILLARY SQUAMOUS CELL CARCINOMA OF THE LARYNX was found to be signifi cantly related to poor survival. 4 All HPV-negative PSCCs stained strongly for p53 presence, and all HPV-positive tumors were negative for p53. 4 Specifi c HPV viral genes act as oncogenes, and it has been hypothesized that these genes form a complex with the p53 protein, functionally inactivating the protein and disrupting its ability to induce cell cycle arrest in response to HPV-induced DNA damage. Th is relationship is evidenced in the uterine cervix, as HPV infection has been shown to have a reciprocal relationship with p53 mutations.
In a study by Dahlstrom et al, male patients with no history of tobacco or alcohol use most commonly presented with HPV-positive oropharyngeal cancers. 10 Our patient demonstrated negative HPV serology results, which is not unexpected considering that the relationship of laryngeal PSCC with HPV has been found to have only a 33 to 43% concordance rate. 4, 11 Our patient did not report a history of papillomatosis at the site of his primary tumor, which would have increased our suspicion for HPV infection.
Because PSCC is associated with a more encouraging prognosis than conventional SCC, we chose to follow our patient with serial laryngeal exams, looking for any evidence of disease recurrence. If this disease does recur, it most commonly presents at the primary tumor site within 1 year of diagnosis. 1 In the Th ompson series, 4 of 12 patients with papillary-type SCC had disease recurrence, and no patients in that group died from the disease. 1 We obtained CT scans in our case, in an eff ort to identify any regional or distant metastases, but it is reasonable to follow a less extensive workup or treatment plan with similar patients because of their localized presentation, poor lymphatic drainage from the vocal folds, and low suspicion for disease progression. Although there has been one unique report of an aggressive form of PSCC that presented with local invasion and metastases at the time of diagnosis, we suspected that this outcome was highly unlikely with our patient based on his presentation and tumor characteristics. 12 We were also reluctant to further treat our patient with radiation therapy and/or more aggressive surgery, as we had the option to treat any recurrent lesion with repeat endoscopic excision and photoablation should one have developed.
In conclusion, we feel this case illustrates the importance of considering malignancy in the diff erential diagnosis of patients with benign-appearing disease, even in cases involving young, healthy patients, especially as the prevalence of HPV-related tumors increases. Although PSCCs of the larynx have a relatively favorable prognosis when compared with conventional SCCs of the head and neck, their correct identifi cation is essential to their proper management. 
